← Back
$UTHR All transactions

UNITED THERAPEUTICS Corp

▼ SELL 10b5-1 Plan

$ Value

$656K

Shares

1,241

Price

$528

Filed

Mar 20

Insider

Name

ROTHBLATT MARTINE A

Title

Chairperson & CEO

CIK

0001106578

Roles

Director Officer

Transaction Details

Transaction Date

2026-03-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

45,782

Footnotes

This exercise of stock options and sale of the resulting shares of common stock was pursuant to a pre-arranged 10b5-1 trading plan adopted by the reporting person on November 7, 2025. This plan will continue until the earlier of: (a) the exercise of 1,734,410 stock options, all of which expire on March 17, 2027; or (b) December 31, 2026. | Shares held in family trusts as to which the Reporting Person shares investment power and the Reporting Person and/or immediate family members are beneficiaries. | Shares held in family trusts as to which the Reporting Person's spouse is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. | Shares held in family trusts as to which the Reporting Person's spouse shares investment power and the Reporting Person and/or immediate family members are beneficiaries. | Shares held in family trusts as to which the Reporting Person is sole trustee and sole beneficiary or co-trustee and settlor with power to revoke. | This transaction was executed in multiple trades at prices ranging from $524.62 to $525.61. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $525.66 to $526.65. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $526.71 to $527.68. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $527.74 to $528.725. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $528.74 to $529.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $529.74 to $530.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $530.74 to $531.66. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. | This transaction was executed in multiple trades at prices ranging from $531.74 to $532.17. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Filing Info

Accession No.

0001106578-26-000016

Form Type

4

Issuer CIK

0001082554

ROTHBLATT MARTINE A's History

Date Ticker Type Value
2026-04-22 UTHR M $1.4M
2026-04-22 UTHR $299K
2026-04-22 UTHR $944K
2026-04-22 UTHR $423K
2026-04-22 UTHR $812K
2026-04-22 UTHR $985K
2026-04-22 UTHR $1.0M
2026-04-22 UTHR $636K
2026-04-22 UTHR $348K
2026-04-22 UTHR M $0

Other Insiders at UTHR (90d)

Insider Bought Sold Last
ROTHBLATT MARTINE A
Chairperson & CEO
$193.1M 2026-04-22
KURZWEIL RAY $2.4M 2026-03-04
PATUSKY CHRISTOPHER $579K 2026-04-17
MAHON PAUL A
EVP & GENERAL COUNSEL
$25.9M 2026-04-16
CAUSEY CHRISTOPHER $1.3M 2026-03-30
Thompson Tommy G $2.1M 2026-03-26
Olian Judy D. $417K 2026-03-23
EDGEMOND JAMES
CFO AND TREASURER
$50.8M 2026-04-20
BENKOWITZ MICHAEL
PRESIDENT AND COO
$60.0M 2026-03-15
MALCOLM JAN $97K 2026-03-17